Samuraciclib improved progression-free survival in HR+ advanced breast cancer patients without TP53 mutations or liver ...

NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary endpoint results ...

I am a 69-year-old woman. I’m in good health despite various events that happened last year (i.e., a hole in my stomach ...

Mereo BioPharma Group plc’s MREO share price has dipped by 5.63%, which has investors questioning if this is right time to ...

BRC Therapeutics (BRC), a pharmaceutical company developing proprietary cannabinoid therapeutics, announced today that Dr.

I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on ...

It is also known as Oxymetholone. Anadrol performs excellently for water retention muscle gain but produces severe liver ...

Combining the cannabinoid cannabinol (CBN) with the breast cancer drug exemestane may significantly improve treatment ...

LTRN A May 5th press release indicated that the FDA cleared Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-184 trial in triple ...

Estrogens are known for their role in reproduction, but a new study reveals that neuroestrogens -- estrogens produced in the brain -- play a key role in appetite regulation. These brain-made hormones ...

The Economic Mobility Pathways Pilot (EMPP) is a program for skilled refugees and displaced people looking to work permanently in Canada. The EMPP: helps skilled refugees and other displaced people ...

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for ...